Regulatory Affairs 2017 Report
Regulatory Affairs 2017
7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR was held during September 25-26, 2017 at Doubletree by Hilton Hotel Chicago, Illinois, USA. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Regulatory professionals, scientists, academicians representing more than 25 countries, who made this conference fruitful and productive.
This conference was based on the theme “Regulatory Challenges and Implications” which included the following scientific tracks:
Regulatory Affairs
Regulatory & Pharmacovigilance
Clinical Affairs & Regulatory Strategies
Regulatory Strategies and Developments
Biologics & Biosimilars
Global Regulatory Intelligence
Regulatory Communications and Submissions
Marketing Authorizations
Regulatory Requirements for Pharmaceuticals
Regulatory Challenges for Medical Devices
Medical Device & Combination Products Regulations
Best Industry Practices
Intellectual Property Rights
Regulatory Affairs 2017 was moderated by Stephen F. Amato, (North Eastern University, Boston, USA)
We are thankful to our below Honourable guests for their generous support and suggestions.
- Michael Drues- Vascular Sciences, USA
- Eliana Silva de Moraes– ABPVS, Brazil
The conference proceedings were carried out through various Scientific-sessions and plenary lectures of which the following topics were highlighted as Keynote-presentations:
- Conducting effective FDA pre-sub meetings: Tell don’t ask... lead don’t follow!: Michael Drues- Vascular Sciences, USA
- Global regulatory challenges and implications– Eliana Silva de Moraes– ABPVS, Brazil
- Convergence of regulatory affairs and reimbursement/market Access, Stephen F. Amato, North Eastern University, USA.
Various sessions were chaired and co-chaired by: Eliana Silva de Moraes - ABPVS, Brazil; Diadelis Remirez Figueredo, Devices and medical equipments (CECMED), Cuba; Stephen F Amato, North Eastern University, USA;
Conference Series LLC has taken the privilege of felicitating Regulatory Affairs 2017 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.
The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Regulatory Affairs 2017. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Pharmaceutical Regulatory Affairs: Open Access as a special issue.
|